BioNTech's low P/E ratio is attributed to investors' expecta...

BioNTech's low P/E ratio is attributed to investors' expectations of continued poor earnings. Shareholders accept this low P/E, anticipating no pleasant surprises in future earnings, suggesting a stagnant share price.